Walgreens Boots Alliance (NASDAQ:WBA) released its quarterly earnings results on Thursday. The pharmacy operator reported $1.47 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.05, Morningstar.com reports. Walgreens Boots Alliance had a return on equity of 21.79% and a net margin of 3.53%. The firm had revenue of $34.59 billion for the quarter, compared to analysts’ expectations of $34.52 billion. During the same quarter last year, the firm posted $1.53 EPS. The company’s revenue was up .7% compared to the same quarter last year. Walgreens Boots Alliance updated its FY19 guidance to ~flat EPS.
Shares of Walgreens Boots Alliance stock opened at $54.67 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.78 and a quick ratio of 0.38. The company has a market cap of $49.98 billion, a price-to-earnings ratio of 9.04, a PEG ratio of 1.12 and a beta of 0.77. The firm’s 50-day moving average price is $52.17. Walgreens Boots Alliance has a 12 month low of $49.31 and a 12 month high of $86.31.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Monday, May 20th were given a dividend of $0.44 per share. The ex-dividend date was Friday, May 17th. This represents a $1.76 annualized dividend and a dividend yield of 3.22%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 29.24%.
Several institutional investors have recently made changes to their positions in the company. Nelson Roberts Investment Advisors LLC bought a new position in Walgreens Boots Alliance during the 1st quarter worth approximately $25,000. Meridian Wealth Management LLC bought a new position in Walgreens Boots Alliance during the 1st quarter worth approximately $25,000. Horan Capital Advisors LLC. bought a new position in Walgreens Boots Alliance during the 1st quarter worth approximately $25,000. Murphy Pohlad Asset Management LLC bought a new position in Walgreens Boots Alliance during the 4th quarter worth approximately $29,000. Finally, Trustcore Financial Services LLC bought a new position in Walgreens Boots Alliance during the 1st quarter worth approximately $31,000. Hedge funds and other institutional investors own 61.52% of the company’s stock.
WBA has been the topic of several recent analyst reports. BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, March 6th. UBS Group lowered their price target on Walgreens Boots Alliance from $70.00 to $65.00 and set a “sell” rating on the stock in a report on Monday, March 4th. Morgan Stanley set a $61.00 price target on Walgreens Boots Alliance and gave the company a “hold” rating in a report on Tuesday, May 14th. Bank of America lowered their price target on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating on the stock in a report on Monday, June 3rd. Finally, Cowen reaffirmed a “hold” rating and issued a $66.00 price target on shares of Walgreens Boots Alliance in a report on Sunday, March 31st. Six analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $63.82.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: Economic Reports
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.